# Dexmedetomidine Versus Propofol in Vitreoretinal Surgery

> **NCT01001429** · PHASE4 · COMPLETED · sponsor: **Rutgers, The State University of New Jersey** · enrollment: 78 (actual)

## Conditions studied

- Retinal Detachment

## Interventions

- **DRUG:** Dexmedetomidine infusion
- **DRUG:** propofol

## Key facts

- **NCT ID:** NCT01001429
- **Lead sponsor:** Rutgers, The State University of New Jersey
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-10
- **Primary completion:** 2013-03
- **Final completion:** 2013-11
- **Target enrollment:** 78 (ACTUAL)
- **Last updated:** 2017-08-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01001429

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01001429, "Dexmedetomidine Versus Propofol in Vitreoretinal Surgery". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01001429. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*